pipette
ENEnglish

PROSPECTIVE COMPARISON OF OPTIMIZED COMPRESSED SENSING AND GRAPPA-ACCELERATED 3D-TOF-MRA FOR EVALUATION OF UNTREATED INTRACRANIAL ANEURYSMS AT 1.5 T: A NON-INFERIORITY STUDY

C. G. Iacoban, H. Bösenberg, C. Klüner, O. Alykova, M. Gerdes, F. Meinert, B. Sundermann, C. Mathys

PreprintUso en el mundo real

En palabras de los autores

RATIONALE AND OBJECTIVES 3D-TOF-MRA is a standard non-invasive method for detecting and monitoring intracranial aneurysms, but long scan times remain a limitation. Compressed sensing (CS) acceleration for intracranial aneurysm evaluation has mainly been studied at 3T. This prospective single-center non-inferiority study compared CS-accelerated 3D-TOF at 1.5T with GRAPPA-accelerated 3D-TOF-MRA for evaluating untreated intracranial aneurysms. MATERIALS AND METHODS Sample size was determined via a preliminary retrospective study. 25 patients with 32 untreated aneurysms underwent both CS- (factor 7, 3:04 min) and GRAPPA-accelerated (factor 2, 5:00 min) 3D-TOF, yielding a 38.7% scan-time reduction. Two blinded neuroradiologists assessed overall image quality (primary endpoint) and artifacts, subjective CNR, aneurysm delineation and diameters (secondary endpoints). Non-inferiority was tested via one-sided t-test (prespecified 10% margin); interrater agreement used ICC. RESULTS CS demonstrated non-inferiority to GRAPPA for overall image quality in both readers (p <= .023), though interrater agreement was low (ICC 0.241-0.262), reflecting subjective variability. Secondary exploratory analyses showed heterogeneous preferences. ROI-based CNR was lower for CS (median 169.6; IQR, 91.0-226. vs. 278.2; 181.0-366.2). Aneurysm diameter measurements showed excellent interrater agreement for both techniques (CS ICC, 0.899-0.980; GRAPPA ICC, 0.877-0.973; all p < .001). CONCLUSION CS-accelerated 3D-TOF at 1.5T met non-inferiority criteria vs. GRAPPA-TOF for overall image quality, reducing scan time by 38.7% while preserving aneurysm measurement reliability. However, reduced CNR and reader-preference variability important trade-offs.

Resultado principalLimitación que admiten los autores

Apareció: miércoles, 4 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.02.26367077